NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for KRN633


Results 1 - 9


Refine Search
Display Mode: Context | Summary
New stem cell research data have been reported by scientists at Pusan National University, Medical Research Institute
2007 MAR 26 ... of hATSCs with anti-VEGF neutralizing antibody or VEGF receptor inhibitors, SU5416 and KRN633, had no significant impact on the OSM induction of SDF-1. Furthermore, treatment of ...
Subject: Stem Cell Research
Price: $3.00
*
Findings in drug development reported from the United States and Japan
2007 FEB 2 ... Baltimore, MD 21205, USA. Study 2: Pharmacological improvements may help KRN633 beat diseases related to pathological angiogenesis. According to recent ...
Subject: Drug Development
Price: $3.00
*
Researchers' data from the United States and Japan advance drug development research
2006 JUN 26 ... E Hanover, NJ 07936, USA. Study 2: Pharmacological improvements may help KRN633 beat diseases related to pathological angiogenesis. According to recent ...
Subject: Drug Development
Price: $3.00
*
Studies describe new findings in drug development research
2006 APR 3 ... new drug development data. Study 1: Pharmacological improvements may help KRN633 beat diseases related to pathological angiogenesis. According to recent ...
Subject: Drug Development
Price: $3.00
*
Pharmacological improvements may help KRN633 beat diseases related to pathological angiogenesis
2006 FEB 27 ... Pharmacological improvements may help KRN633 beat diseases related to pathological angiogenesis. According to recent ...
Subject: Drug Development
Price: $3.00
*
New findings in enzymology described
2005 JUL 25 ... 145 King Prussia Rd., Mail Stop R-4-2, Radnor, PA 19087, USA. Study 2: KRN633 eliminates angiogenic growth in solid tumors. According to a study from ...
Subject: Enzymology
Price: $3.00
*
New findings in the area of enzymology detailed
2005 MAY 30 ... Science, 1011 N University, Rm 2309, Ann Arbor, MI 48109, USA. Study 2: KRN633 eliminates angiogenic growth in solid tumors. According to a study from ...
Subject: Enzymology
Price: $3.00
*
Recent findings in enzymology described
2005 APR 8 ... advances have been reported from Japan and the United States. Study 1: KRN633 eliminates angiogenic growth in solid tumors. According to a study from ...
Subject: Enzymology
Price: $3.00
*
KRN633 eliminates angiogenic growth in solid tumors
2005 MAR 11 ... KRN633 eliminates angiogenic growth in solid tumors. According to a study from ...
Subject: Enzymology
Price: $3.00
*

Results 1 - 9




-----------------------
PR Login